Cancer Trend Report Highlights Specialty Pharmacy Week in Review

Top stories of the week on Specialty Pharmacy Times from May 25 to May 29.

New Cancer Cases Rise as Cancer Deaths Fall

Treatment advances have caused significant progress in survivorship.

http://www.specialtypharmacytimes.com/news/New-Cancer-Cases-Rise-as-Cancer-Deaths-Fall

Redesigned Antibody May Control HIV Infection

Discovery may accelerate search for effective vaccine.

http://www.specialtypharmacytimes.com/news/Redesigned-Antibody-May-Control-HIV-Infection

Can Providers Predict Which Patients Will Respond to Multiple Sclerosis?

Genetic variant found to be associated with the likelihood of patient response to interferon-beta.

http://www.specialtypharmacytimes.com/news/Can-Providers-Predict-Which-Patients-Will-Respond-to-Multiple-Sclerosis

New Insulin Pen Strength Gets FDA Nod

Treatment is the first concentrated mealtime insulin analog to be approved by the FDA.

http://www.specialtypharmacytimes.com/news/New-Insulin-Pen-Strength-Gets-FDA-Nod

New Treatment Target Found for Rheumatoid Arthritis

Novel drug target found in cells directly responsible for cartilage damage in affected joints.

http://www.specialtypharmacytimes.com/news/New-Treatment-Target-Found-for-Rheumatoid-Arthritis

Psoriasis Drug Development Pact Dissolved Due to Suicide Concerns

Treatment blocks signals that may lead to inflammation.

http://www.specialtypharmacytimes.com/news/Psoriasis-Drug-Development-Pact-Dissolved-Due-to-Suicide-Concerns

Molecular Treatment Strategy May Kill Lung Cancer Cells

Protein that helps cancer cells avoid death offers promising target.

http://www.specialtypharmacytimes.com/news/Molecular-Treatment-Strategy-May-Kill-Lung-Cancer-Cells

Immune Cell Injections Safe and Effective for Multiple Myeloma

Treatment utilizes immune cells grown from patient bone marrow to treat multiple myeloma.

http://www.specialtypharmacytimes.com/news/Immune-Cell-Injections-Safe-and-Effective-for-Multiple-Myeloma

FDA Approves Treatment for Rare Lung Disease

Patients who took the drug had a slower decline in lung function than those on placebo.

http://www.specialtypharmacytimes.com/news/FDA-Approves-Treatment-for-Rare-Lung-Disease

Vaccine Vial Monitor Systems Critical in Polio Eradication Effort

Monitors alert health workers when a vaccine has potentially been compromised by cold chain failures.

http://www.specialtypharmacytimes.com/news/Vaccine-Vial-Monitor-Systems-Critical-in-Polio-Eradication-Effort